ReviewCureus2025
The Role of Mammalian Target of Rapamycin (mTOR) and Adenosine Monophosphate-Activated Protein Kinase (AMPK) Signaling in Skeletal Muscle Hypertrophy: A Literature Review With Implications for Health and Disease.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- AMPK/ SIRT1 signaling pathway activation acts on PGC-1α/ PPARγ to alleviate sepsis-acquired weakness.Cell death discovery · 2026Article
- Sarcopenia and Frailty in COPD: Mechanisms, Relationship with Malnutrition and Potential Therapeutic Interventions.Nutrients · 2026Review
- Integrated Multivariate Analysis and Desirability-Based Optimization of Milk-Whey Mixtures: Effects on Physicochemical Properties, Amino Acid Profile, and Nutritional Quality.Foods (Basel, Switzerland) · 2026Article
- Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications for Human Aging and Longevity.Nutrients · 2026Review
- Sarcopenia and sepsis fuel a self-perpetuating cycle of immunometabolism decline.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintaining skeletal muscle mass is fundamental not only for strength and mobility but also for metabolic health, disease prevention, and healthy aging. Skeletal muscle functions as a dynamic metabolic organ, and its maintenance depends on the delicate equilibrium between mammalian target of rapamycin (mTOR), which drives anabolic processes, such as protein synthesis and hypertrophy, and adenosine monophosphate-activated protein kinase (AMPK), which promotes catabolic renewal through mitochondrial biogenesis, autophagy, and energy conservation. Sustained mTOR hyperactivation contributes to obesity, insulin resistance, neurodegeneration, and cancer, while AMPK activation counterbalances these effects by restoring cellular energy balance and enhancing metabolic resilience. Thus, optimal muscle and metabolic health depend not on dominance of one pathway, but on the strategic balance between mTOR and AMPK activity. Human trials and meta-analyses show that for individuals engaged in resistance training, a total protein intake of approximately 1.6 g/kg/day effectively maximizes muscle protein synthesis, with diminishing returns beyond that level. Distributing protein evenly across meals enhances anabolic efficiency, about 0.25 g/kg per meal in younger adults and 0.40 g/kg per meal in older adults, which helps overcome age-related anabolic resistance. Protein quality is equally critical: leucine-rich, rapidly absorbed sources such as whey elicit the most robust mTOR activation and muscle-building response. Exercise mode and energy timing further shape this anabolic-catabolic balance. Concurrent endurance and resistance training may attenuate hypertrophy depending on session order, intensity, and training status, whereas intermittent fasting and time-restricted feeding improve body composition and cardiometabolic health when total energy and protein needs are still met. Together, these findings suggest that integrating structured resistance exercise, well-distributed, high-quality protein intake, and periodic AMPK activation through fasting or aerobic training provides a practical framework for sustaining muscle mass, optimizing metabolic function, and promoting longevity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.